Vistagen Therapeutics (VTGN) Common Equity (2011 - 2026)
Vistagen Therapeutics' Common Equity came in at $24.48 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 56.9% from $56.77 million a year earlier and down 31.1% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Common Equity (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Common Equity was $35.52 million, down 49.5% from FY2025.
- Common Equity carries a five-year compound annual growth rate of -17.3% (FY2021 to FY2026).
- Going back by fiscal year, Common Equity was $70.39 million in FY2025 (-38.4%), $114.29 million in FY2024 (+846.1%), $12.08 million in FY2023 (-81.3%) and $64.72 million in FY2022 (-29.6%).
- The fiscal Q1 2027 figure represents the lowest quarterly Common Equity since fiscal Q1 2024.
- Year-over-year, Common Equity has declined for seven consecutive quarters, with an average decline of 16.2% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in fiscal Q4 2024 (growth of 846.1%), and the weakest in fiscal Q1 2024 (a decline of 85.1%).
- Business Quant data shows VTGN's Common Equity at $35.52 million (Q4 2026), $50.92 million (Q3 2026) and $66.34 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - | 24.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.48 Mn |
| Mar 31, 2026 | 35.52 Mn |
| Dec 31, 2025 | 50.92 Mn |
| Sep 30, 2025 | 66.34 Mn |
| Jun 30, 2025 | 56.77 Mn |
| Mar 31, 2025 | 70.39 Mn |
| Dec 31, 2024 | 81.12 Mn |
| Sep 30, 2024 | 92.97 Mn |
| Jun 30, 2024 | 104.80 Mn |
| Mar 31, 2024 | 114.29 Mn |
| Dec 31, 2023 | 123.29 Mn |
| Sep 30, 2023 | 35.65 Mn |
| Jun 30, 2023 | 6.85 Mn |
| Mar 31, 2023 | 12.08 Mn |
| Dec 31, 2022 | 20.67 Mn |
| Sep 30, 2022 | 29.61 Mn |
| Jun 30, 2022 | 46.05 Mn |
| Mar 31, 2022 | 64.72 Mn |
| Dec 31, 2021 | 79.98 Mn |
| Sep 30, 2021 | 80.66 Mn |
API Access
Vistagen Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();